RE:RE:RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A DealsI agree Johnny
the easy deals can be quick. The more complicated, involved deals take longer time.
The writing is on the wall, for all to see.
Yes there was a high risk deal on the table years ago. Onc wanted more $$.
pfizer & Merck asked for more proof of MOA to justify the higher price.
that proof is coming to fruition.
The recent fda meeting being a huge step in the right direction.
Especially noted the application was coauthoured by the collaborating pharma potential partners.
everyone wants this to work.
still comes back to pending FDA approval for phase 3 & upcoming additional trial results.
all the best everyone.